/CSL

CSL

Updated 10 July 08:16 am

$122.35

CSL LIMITED

1D-2.53%
1M+19.50%
1Y-48.00%
Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Track your position in CSL

Sign in to TradeLedgr to record trades in CSL (CSL LIMITED) with parcel-level precision and ATO-compliant reporting.

Recent Announcements

07 Jul 2026 6:31 AM
12KB
Notification of cessation of securities - CSL
Appendix 3H (Notification of cessation of securities)
28 Jun 2026 11:31 PM
134KB
Update on TAVNEOS
Progress Report
09 Jun 2026 6:33 AM
12KB
Notification of cessation of securities - CSL
Appendix 3H (Notification of cessation of securities)
04 Jun 2026 10:23 PM
204KB
Appendix 3Y - Carolyn Hewson AO
Change of Director's Interest Notice
02 Jun 2026 10:53 PM
17754KB
Change in substantial holding
Change in substantial holding

Fundamentals

P/E Ratio

24.33x

Div Yield

435.16%

EPS

$4.0246

Avg Vol

1.6M

52W High

$275.790

52W Low

$90.000

Company Profile

Development, manufacturing and marketing of pharmaceutical and diagnostic products, cell culture media and human plasma fractions.

Corporate Website

Financial History

2025A

$3002.0M profit

$15558.0M rev

2024A

$2642.0M profit

$14800.0M rev

2023A

$2194.0M profit

$13310.0M rev